| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.8M | +18.5% |
| R&D Expense | $10.6M | +9.2% |
| SG&A Expense | $9.9M | +16.3% |
| Operating Income | -$14.7M | -10.3% |
| Income Tax | $0 | — |
| Net Income | -$13.0M | +2.5% |
| EPS (Basic) | -$1.95 | +54.0% |
| EPS (Diluted) | -$2.34 | +44.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76K | -99.1% |
| Short-term Investments | $3.5M | — |
| Current Assets | $5.3M | -46.5% |
| Total Assets | $6.6M | -41.8% |
| Current Liabilities | $15.6M | +45.0% |
| Total Liabilities | $15.6M | +22.3% |
| Stockholders' Equity | -$8.9M | -563.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.6M | +17.9% |
| Capital Expenditures | $146K | -8.8% |
| Investing Cash Flow | -$4.1M | -2469.4% |
| Financing Cash Flow | $6.2M | +79.6% |
| Free Cash Flow | -$10.7M | +17.8% |